Found: 31
Select item for more details and to access through your institution.
Rifampin Enhances the Glucose-Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 416, doi. 10.1038/clpt.2010.266
- By:
- Publication type:
- Article
Pharmacogenomics of the RNA World: Structural RNA Polymorphisms in Drug Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 355, doi. 10.1038/clpt.2010.314
- By:
- Publication type:
- Article
Ethical Issues in Developing Pharmacogenetic Research Partnerships With American Indigenous Communities.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 387, doi. 10.1038/clpt.2010.320
- By:
- Publication type:
- Article
ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 422, doi. 10.1038/clpt.2010.348
- By:
- Publication type:
- Article
Year in Review.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Physician Barriers to Incorporating Pharmacogenetic Treatment Strategies for Nicotine Dependence Into Clinical Practice.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 345, doi. 10.1038/clpt.2010.267
- By:
- Publication type:
- Article
Early Human Screening of Medications to Treat Drug Addiction: Novel Paradigms and the Relevance of Pharmacogenetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 460, doi. 10.1038/clpt.2010.254
- By:
- Publication type:
- Article
Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 437, doi. 10.1038/clpt.2010.351
- By:
- Publication type:
- Article
Hepatocyte Proliferation and Hepatitis C Virus Kinetics During Treatment.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone Soluble-Films.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 443, doi. 10.1038/clpt.2010.352
- By:
- Publication type:
- Article
Pharmacogenomics: 'Noninferiority' Is Sufficient for Initial Implementation.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
What to Expect From the Pharmacogenomics Research Network.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 339, doi. 10.1038/clpt.2010.293
- By:
- Publication type:
- Article
The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 408, doi. 10.1038/clpt.2010.322
- By:
- Publication type:
- Article
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 400, doi. 10.1038/clpt.2010.318
- By:
- Publication type:
- Article
CORRIGENDUM: A Concise Display of Multiple End Points for Benefit-Risk Assessment.
- Published in:
- 2011
- Publication type:
- Correction notice
In This Issue.
- Published in:
- 2011
- Publication type:
- Abstract
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 336, doi. 10.1038/clpt.2010.363
- Publication type:
- Article
CORRIGENDUM: Abstract PIII-59: The Pharmacokinetics of YM150, an Oral Direct Factor XA Inhibitor, Exhibits Dose Proportionality with no Clinically Relevant Effect of Ethnicity or Gender.
- Published in:
- 2011
- Publication type:
- Correction notice
The Emerging Therapeutic Role of RNA Interference in Disorders of the Central Nervous System.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 450, doi. 10.1038/clpt.2010.312
- By:
- Publication type:
- Article
CYP2D6 in the Brain: Impact on Suicidality.
- Published in:
- 2011
- By:
- Publication type:
- Letter
ERRATUM: Are Circulating Metabolites Important in Drug-Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory Potency.
- Published in:
- 2011
- Publication type:
- Correction notice
Pharmacogenomics at the Tipping Point: Challenges and Opportunities.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
The Emerging Role of Electronic Medical Records in Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 379, doi. 10.1038/clpt.2010.260
- By:
- Publication type:
- Article
Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 392, doi. 10.1038/clpt.2010.317
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 334, doi. 10.1038/clpt.2010.362
- Publication type:
- Article
Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 366, doi. 10.1038/clpt.2010.315
- By:
- Publication type:
- Article
Lack of Evidence for Exposure-Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections.
- Published in:
- 2011
- By:
- Publication type:
- Letter
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 464, doi. 10.1038/clpt.2010.279
- By:
- Publication type:
- Article
Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 455, doi. 10.1038/clpt.2010.316
- By:
- Publication type:
- Article
Can Modeling of Health Outcomes Facilitate Regulatory Decision Making?: The Benefit-Risk Tradeoff for Rosiglitazone in 1999 vs. 2007.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 429, doi. 10.1038/clpt.2010.350
- By:
- Publication type:
- Article